Can a one-time shot fix bad cholesterol?
Original Title
Abstract 4139206: Design of Heart-2: a phase 1b clinical trial of VERVE-102, an in vivo base editing medicine delivered by a GalNAc-LNP and targeting PCSK9 to durably lower LDL cholesterol
Data Sources
Data sources we collected to analyse this study.
Full Text
PDF
Crossref
PubMed
Classification
Summary
Quality Score
Content
Study Identifiers & Links
Access this study on other platforms